Investment Rating - The investment rating for the company is "Buy-A" and is maintained [7] Core Views - The company has shown steady revenue growth, with a projected revenue of 1.13 billion yuan for 2024, representing a year-on-year increase of 10.8%. The net profit attributable to shareholders is expected to be 186 million yuan, up 15% year-on-year [7] - The revenue structure is continuously optimizing, with high growth contributions from testing instruments and professional instruments. The domestic market has seen significant expansion, achieving a revenue of 511 million yuan, a year-on-year increase of 20.7% [3][4] - The company is expected to benefit from supportive policies and increased capital expenditure in downstream sectors, which will bolster demand for instruments and new orders [5] Summary by Relevant Sections Financial Performance - For the reporting period, the company achieved an operating income of 1.13 billion yuan, a 10.68% increase year-on-year. The net profit attributable to shareholders was 186 million yuan, reflecting a 15% growth [3][4] - The gross profit margin has improved, driven by an increase in the sales proportion of mid-to-high-end products [4] Future Outlook - The company anticipates steady growth in 2025, driven by several factors including supportive government policies and the introduction of over 30 new instrument products planned for 2025 [5] - The completion of the Vietnam factory is expected to enhance international competitiveness, with large-scale production anticipated in Q2 to Q3 of 2025 [5] Valuation Metrics - The projected earnings per share (EPS) for 2024, 2025, and 2026 are 1.67 yuan, 2.13 yuan, and 2.55 yuan respectively, with corresponding price-to-earnings (P/E) ratios of 23.5, 18.4, and 15.4 [7][12]

Investment Rating - The investment rating for the company is "Buy-A" and is maintained [6] Core Views - The company reported a revenue of 1.13 billion yuan for the fiscal year 2024, representing a year-on-year growth of 10.80%. The net profit attributable to shareholders is expected to be 186 million yuan, with a year-on-year increase of 15.02% [1][6] - The company's revenue structure is continuously optimizing, with high growth contributions from testing instruments and professional instruments. The domestic market showed significant growth, achieving a revenue of 511 million yuan, up 20.70% year-on-year, while the overseas market revenue was 614 million yuan, up 3.53% year-on-year [2][3] Financial Performance - The company’s total market capitalization is 4.357 billion yuan. The gross profit margin has improved year-on-year, leading to a net profit growth rate that exceeds revenue growth [3] - The company plans to increase its revenue to 1.48 billion yuan by 2026, with net profits projected at 283 million yuan. The earnings per share (EPS) are expected to be 1.7, 2.1, and 2.6 yuan for the years 2024, 2025, and 2026 respectively [6][8] Strategic Outlook - The company is expected to achieve steady growth in 2025, driven by policies supporting capital expenditure and the acceleration of high-end product sales. The company has launched over ten new testing instruments since 2024 and plans to introduce more than 30 new products in 2025 [4] - The completion of the Vietnam factory is anticipated to enhance international competitiveness, with large-scale production expected to commence in the second to third quarter of 2025 [4]

Investment Rating - The report maintains a "Buy-A" investment rating for the company [7] Core Views - The company is expected to achieve steady revenue growth driven by high-end, specialized, and international strategies, with significant contributions from testing instruments and professional instruments [3][5] - The revenue structure is continuously optimizing, with an increase in the proportion of mid-to-high-end products, leading to a higher growth rate in net profit compared to revenue [4][5] Summary by Relevant Sections Financial Performance - For the fiscal year 2024, the company anticipates revenue of 1.13 billion yuan, a year-on-year increase of 10.8%, and a net profit of 186 million yuan, reflecting a 15% growth [7] - The company reported a revenue of 1.13 billion yuan for the reporting period, with a 10.68% increase in main business revenue, and a notable 20.7% growth in domestic market revenue [3][4] Revenue Structure - The revenue from testing instruments and professional instruments has outpaced overall growth, while general instruments and temperature/environment testing instruments have seen slower growth [4] - The company has increased its R&D investment, with R&D expenses rising by 13.63% year-on-year, which is expected to enhance long-term competitiveness despite short-term profit impacts [4] Future Outlook - The company is projected to continue its robust growth in 2025, supported by policies and increased capital expenditure in downstream sectors, as well as the introduction of over 30 new instrument products [5][7] - The completion of the Vietnam factory is expected to enhance international competitiveness, with large-scale production anticipated in mid-2025 [5]

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Views - The company achieved a revenue of 1.13 billion yuan in 2024, representing a year-on-year growth of 10.80%. The net profit attributable to the parent company was 186 million yuan, with a growth of 15.02% year-on-year [1][4]. - The company is focusing on high-end, specialized, and international strategies, which have significantly contributed to its revenue growth. The domestic market showed strong performance with a 20.70% increase in main business revenue [2][4]. - The company has successfully launched several innovative products and established long-term collaborations with 83 universities, enhancing its talent cultivation platform [3]. Financial Performance - The company is projected to achieve revenues of 1.13 billion yuan, 1.27 billion yuan, and 1.44 billion yuan for the years 2024, 2025, and 2026, respectively. The net profit for the same years is expected to be 186 million yuan, 211 million yuan, and 242 million yuan [4][8]. - The company's return on equity (ROE) is forecasted to increase from 15.01% in 2024 to 16.40% in 2026 [10]. - The earnings per share (EPS) is expected to grow from 1.67 yuan in 2024 to 2.17 yuan in 2026, with corresponding price-to-earnings (P/E) ratios decreasing from 23.15 to 17.77 [4][10]. Product Development and Market Strategy - The company has a broad product line and continues to innovate, with several new high-end testing instruments launched in late 2024 [3]. - The company emphasizes technology innovation as a core driver, with R&D expenses increasing by 13.63% year-on-year [2][3]. - The successful execution of high-end, specialized, and international strategies has led to significant growth in both domestic and international markets [2][4].

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Views - The company has demonstrated steady revenue growth, achieving a revenue of 1.13 billion yuan in 2024, which represents a year-on-year increase of 10.80%. The net profit attributable to the parent company reached 186 million yuan, up 15.02% year-on-year [1][4]. - The company is focusing on high-end, specialized, and international strategies, which have significantly contributed to its revenue growth. The domestic market showed strong performance with a 20.70% increase in main business revenue, while the overseas market grew by 3.53% [2][4]. - The company continues to invest in research and development, with R&D expenses increasing by 13.63% during the reporting period, reflecting its commitment to technological innovation [2][3]. Summary by Sections Financial Performance - In 2024, the company achieved a total asset value of 1.707 billion yuan, marking an 18.51% increase year-on-year. The main business revenue was 1.126 billion yuan, with a year-on-year growth of 10.68% [1][2]. - The company’s net profit for 2024 was 185.64 million yuan, with a year-on-year growth of 15.03% [4][8]. Product Development - The company has a broad product line and has successfully registered the T-Mix adaptive dual-light image fusion algorithm. It showcased innovative products at major conferences, including high-resolution oscilloscopes and signal analyzers [3][4]. - The company has established long-term collaborations with 83 universities, contributing to talent development in the power electronics industry [3]. Future Projections - The company is expected to achieve revenues of 1.272 billion yuan in 2025 and 1.439 billion yuan in 2026, with corresponding net profits of 210.69 million yuan and 241.86 million yuan, respectively [4][8]. - The earnings per share (EPS) are projected to be 1.89 yuan in 2025 and 2.17 yuan in 2026, with a decreasing price-to-earnings (P/E) ratio forecasted at 20.40 and 17.77 times [4][8].

Company and Industry Summary Company Overview - The company reported a revenue of 1.13 billion in 2024, representing a year-on-year growth of 10.8% [1] - Domestic revenue reached 510 million, with a significant increase of 20.7% year-on-year [1] - Overseas revenue was 610 million, showing a growth of 3.53% [1] Key Financial Insights - The increase in revenue was attributed to continuous optimization of the product structure, with an overall gross margin improvement of nearly 2 percentage points, exceeding 45% [2] - Net profit growth was impacted by additional stock incentive expenses and a donation to Zhejiang University for an electronic engineering training lab, which was delivered ahead of schedule [2] - Shipping delays affected approximately 5-6 million in orders, resulting in a profit impact of 1-2 million [3] Future Outlook - For Q1 2025, the company anticipates a revenue growth of around 15% year-on-year, with optimistic order and shipment trends [4] - Expected net profit growth for Q1 2025 is projected at 25% year-on-year [4] - Total expenses for 2025 are expected to increase by 10-15%, which is anticipated to be slower than revenue growth [5] Industry Trends and Developments - The company is exploring collaborations in the robotics sector, particularly in integrating testing instruments with robotic applications [6][7] - There is a focus on developing high-risk testing scenarios where robots can replace manual testing in power stations [8] - The company is also working on AI integration in their instruments to enhance user experience and reduce operational complexity [11][22] Market Dynamics - The company noted that the ODM business had a revenue of approximately 280 million last year, with expectations to recover to over 300 million this year [14] - The overseas market for self-branded instruments is showing signs of recovery, with projected growth of 40-50% in Q1 [15] - The company is also focusing on self-developed chips for their products, with plans to release new high-bandwidth chips [16] Competitive Landscape - The company is positioned to benefit from the trend of domestic enterprises preferring local manufacturers, particularly in the power and electrical sectors [18] - The integration of various testing instruments into robotic systems is seen as a unique selling point that could enhance market competitiveness [23][24] Conclusion - The company is optimistic about its performance in 2025, with a strong focus on innovation in product development and strategic partnerships in the robotics field [29] - Continued emphasis on enhancing operational efficiency and user experience through AI and automation is expected to drive future growth [22]

Financial Performance - In 2024, the company achieved total operating revenue of CNY 1,130,340,251.37, representing a year-on-year increase of 10.80%[3] - The net profit attributable to shareholders of the parent company reached CNY 185,635,022.53, up 15.02% compared to the previous year[3] - The net profit after deducting non-recurring gains and losses was CNY 178,111,527.01, reflecting a growth of 17.26% year-on-year[3] - The basic earnings per share rose to CNY 1.68, up 15.07% from CNY 1.46 in the previous year[3] - The weighted average return on net assets improved to 15.24%, an increase of 0.89 percentage points from the previous year[3] Asset Growth - The company's total assets at the end of the reporting period were CNY 1,707,457,966.49, an increase of 18.51% from the beginning of the period[3] Market Performance - Domestic market revenue grew significantly, reaching CNY 51,127,450, a 20.70% increase year-on-year[6] - The overseas market generated revenue of CNY 61,423,650, marking a 3.53% increase compared to the previous year[6] Research and Development - The company’s R&D expenses increased by CNY 1,413,520, representing a 13.63% rise compared to the previous year, indicating a strong focus on technological innovation[6] Incentive Plans - The company implemented a stock incentive plan, with recognized equity incentive expenses amounting to CNY 7,684,800 during the reporting period[6]

证券代码：688628 证券简称：优利德 公告编号：2025-002 优利德科技(中国)股份有限公司 关于股份回购实施结果暨股份变动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2024/2/21，由实际控制人、董事长、总经理洪少 | | | | --- | --- | --- | --- | | | 俊先生提议 | | | | 回购方案实施期限 | 年 月 日~2025 年 月 2024 2 2 18 | 19 | 日 | | 预计回购金额 | 2,500 万元~5,000 万元 | | | | 回购价格上限 | 49.60 元/股 □减少注册资本 | | | | 回购用途 | √用于员工持股计划或股权激励 □用于转换公司可转债 | | | | | □为维护公司价值及股东权益 | | | | 实际回购股数 | 万股 74.49 | | | | 实际回购股数占总股本比例 | 0.6694% | | | | 实际回购金额 | 万元 2,538.04 | | | | 实际回购价 ...

证券代码：688628 证券简称：优利德 公告编号：2025-001 优利德科技(中国)股份有限公司 关于以集中竞价交易方式回购公司股份的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2024/2/21，由实际控制人、董事长、总经理洪少 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | | 俊先生提议 | | | | | | | 回购方案实施期限 | 年 月 年 月 2024 2 | 19 | 日~2025 | 2 | 18 | 日 | | 预计回购金额 | 万元~5,000 万元 2,500 | | | | | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | | | | | | □用于转换公司可转债 | | | | | | | | □为维护公司价值及股东权益 | | | | | | | 累计已回购股数 | 万股 74.49 | | | | | | | 累计已回购股数占总股本 ...

一、监事会会议召开情况 优利德科技（中国）股份有限公司（以下简称"公司"）第三届监事会第七 次会议于 2024 年 12 月 6 日在公司会议室以现场方式召开，会议通知于 2024 年 12 月 3 日通过邮件形式送达公司全体监事。本次会议由监事会主席杨正军先 生主持，应出席监事 3 名，实际出席监事 3 名。 本次会议的召集、召开和表决程序均符合《公司法》和《公司章程》的有关 规定，会议合法有效。 证券代码：688628 证券简称：优利德 公告编号：2024-090 优利德科技（中国）股份有限公司 第三届监事会第七次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 特此公告。 优利德科技（中国）股份有限公司监事会 2024 年 12 月 7 日 1 （一）审议通过《关于增加募投项目投资额及调整募投项目实施进度的议案》 监事会认为：公司本次增加募投项目投资额及调整募投项目实施进度事项是 公司根据募投项目的实际情况作出的合理调整和科学安排，不会对公司的正常经 营产生影响。有关的决策和审批程序符合《上市公司监管指引第 ...